癌症临床试验

Clinical trials are research studies for cancer treatments that are still in the development phase.

The 我的健康 癌症中心 is committed to participation in clinical trials for our patients on a case-by-case basis. 作为…的附属会员 NRG肿瘤学, we have the ability to offer clinical trials associated with the leading oncology research centers and national cooperative groups.

注意这一点很重要, 有很多原因, not all patients will be eligible for a clinical trial. There are very strict patient eligibility requirements that are specific to each clinical trial.  We look forward to the opportunity to discuss this possible option with you.

Clinical trials are done in phases. Each phase has a different purpose, the National Institute of Health says:

• Phase I trials use a small group of people, 通常20 - 80, 检查安全, dosage and side effects of a treatment.
• Phase II trials expand to 100-300 people and look at the effectiveness and safety of a treatment.
• III期试验包括1,000-3,000 people and try to confirm the results of the earlier trials and compare the new treatment with other commonly used treatments.

蒙生人气最高的现金网赌软件下载 primarily focuses on Phase II and Phase III trials. If interested, please speak to your doctor or call our Clinical Trial Coordinator at 304-598-6581.

Open 临床试验 for 血液学 肿瘤学

S1207:  III期随机, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of Everolimus in patients with high-risk hormone receptor-positive AND HER2/neu negative breast cancer.   

ECOG-EAY131: 匹配研究 - A Phase II precision medicine trial that seeks to determine whether matching certain drugs or drug combinations in adults whose tumors have specific gene abnormalities will effectively treat their cancer, regardless of their cancer type.

Open 临床试验 for 妇科肿瘤

ProMark:  A Collaborative Study with The University of Pittsburgh Medical Centers. Prognostic Marker: Acquisition of Blood Samples and Tissue for Research Purposes. 

NRG-GY005: A Randomized Phase II/III study of the combination of Cebiranib and Olaparib compa红色的 to Cediranib or Olaparib alone, of standard of care chemotherapy in women with recurrent platinum-resistant or refractory ovarian, fallopian tube or primary peritoneal cancer (COCOS).

ICON-eXACT sCIENCES 2018-01: Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors

NRG-GY009 - TEMPORARILY CLOSED TO ACCURAL:随机, Phase II/III study of pegylated liposomal doxorubicin and CTEP-supplied Atezolizumab (IND #134427) versus pegylated liposomal doxorubicin/bevacizumad and CTEP-supplied atezolizumab versus pegylated liposomal doxorubicin/bevacizumab in platinum resistant ovarian cancer.

NRG-GY018 - WILL BE OPENING IN THE NEXT FEW WEEK: III期随机, placebo-controlled study of pembrolizumab (MK-3475, NSC #776864) in addition to paclitaxel and carboplatin for measurable stage III or IVA, stage IVB or recurrent endometrial cancer.

If you would like to learn 更多的 about clinical trials, here are some useful links:

临床试验.政府—a worldwide clinical studies database from the US National Institutes of Health 
癌症.政府—a cancer-specific resource on clinical trials from the National 癌症 Institute at the National Institutes of Health
NRG肿瘤学 – a resource for the clinical trials by the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy 肿瘤学 Group (RTOG) and the 妇科肿瘤 Group (GOG)